Physician profile
Ala Mustafa
NPI 1235795089
$7,154.33
in general payments reported to CMS, 2019-2025
13 companies · $4,613 in 2025
The $4,613 reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.64 · 2020: $14.19 · 2023: $440 · 2024: $1,987 · 2025: $4,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,718 · Food and Beverage: $1,972 · Grant: $682 · Education: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,717.86 |
| Food and Beverage | $1,971.99 |
| Grant | $682.00 |
| Education | $668.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,924.24 | 2024-2025 | Impella |
| Abbott Laboratories | $1,724.36 | 2023-2025 | Gallant, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary |
| Edwards Lifesciences Corporation | $1,646.05 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,070.19 | 2024-2025 | Rotablator Rotational Atherectomy System Console Kit, Opticross, General - Vascular Access |
| Medtronic, INC. | $211.90 | 2025 | Resolute Onyx, Symplicity G3 |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2023 | Brilinta |
| Lundbeck LLC | $99.64 | 2019 | |
| Heartflow, INC. | $79.59 | 2025 | |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
| Cardiva Medical, INC. | $48.97 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Stryker Corporation | $36.96 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.44 | 2020-2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ala Mustafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.